Literature DB >> 3076966

Dysgonic Fermenter-type 2: an emerging zoonosis. Report of two cases and review.

A Zumla1, G Lipscomb, M Corbett, M McCarthy.   

Abstract

We report Dysgonic Fermenter-type 2 septicaemia presenting in two previously healthy individuals, and review 52 cases of infection with Dysgonic Fermenter-type 2 reported in the English language literature. This zoonosis is usually acquired through contact with dogs and cats. Infection often presents with little warning to patient or physician and carries a high mortality. The immunosuppressed patient, those without a spleen, alcoholics and those with chronic disease appear to be most susceptible, although the healthy individual is also prone to infection. The infection is probably underdiagnosed due to difficulties in isolating Dysgonic Fermenter-type 2 by conventional blood culture techniques. Clinical and microbiological awareness is of prime importance in the early diagnosis of this potentially lethal infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3076966

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  5 in total

Review 1.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

2.  Clinical illnesses associated with isolation of dysgonic fermenter 3 from stool samples.

Authors:  R N Blum; C D Berry; M G Phillips; D L Hamilos; E W Koneman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

3.  Secretory diarrhea following a dog bite.

Authors:  R M Peek; C Truss
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

Review 4.  Capnocytophaga canimorsus septicemia: fifth report of a cat-associated infection and five other cases.

Authors:  M Valtonen; A Lauhio; P Carlson; J Multanen; A Sivonen; M Vaara; J Lähdevirta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

5.  DF2 septicaemia.

Authors:  R J Evans
Journal:  J R Soc Med       Date:  1991-12       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.